Dasanat 50, Dasatinib, Leukemia Treatment, Targeted Cancer Therapy, ZarvyPharm
AntiCancer Drugs Blood Cancer

Dasanat 50

★★★★★
★★★★★
5

(2)

Generic For SPRYCEL
Active Ingredient DASATINIB
Strength 50MG
Manufacturer NATCO PHARMA LTD
Dasanat 50 60 Tablets front box packaging
Dasanat 50 60 Tablets blister strip close-up
Dasanat 50 60 Tablets box with outer carton
Dasanat 50 60 Tablets front box packaging
Dasanat 50 60 Tablets blister strip close-up
Dasanat 50 60 Tablets box with outer carton
Best available coupon applied for preview!
Use code ZARVY26 at checkout to get 15% OFF your order.
COUPON CODE
ZARVY26
15% OFF
Pack Size Price Per Unit Unit Price QTY CART Best Coupon Price
MAX DISCOUNT
1 BOX - 60 TABLETS $ 1.17 $ 70.00
$ 59.50
Apply ZARVY26 (-15%)
You save $ 10.50
2 BOXES - 120 TABLETS $ 1.23 $ 148.00
$ 125.80
Apply ZARVY26 (-15%)
You save $ 22.20
★ Best Value 3 BOXES - 180 TABLETS $ 1.26 $ 226.00
$ 192.10
Apply ZARVY26 (-15%)
You save $ 33.90

Exchange & Returns Information

 

 

Reference

Reference information will be available soon.

Product Description

Dasanat 50 is a generic dasatinib formulation indicated for the treatment of Philadelphia chromosome-positive leukemias. As a potent second-generation tyrosine kinase inhibitor (TKI), it exhibits strong activity against BCR-ABL mutations, including imatinib-resistant variants, and inhibits multiple SRC-family kinases. This broader kinase inhibition leads to rapid hematologic and cytogenetic responses, making it a preferred option in advanced and high-risk cases of CML and Ph+ ALL. Its ability to penetrate the CNS also allows for effective prophylaxis or treatment of central nervous system involvement in leukemia.

Indications & Uses

- AntiCancer Drugs > Chronic Myeloid Leukemia (CML) Dasanat 50 is primarily indicated for adults with Ph+ CML in chronic, accelerated, or blast crisis phases, especially for those who are resistant or intolerant to imatinib. It is also approved as a first-line treatment for newly diagnosed chronic phase CML in high-risk patients. Its rapid onset and deep molecular response contribute to improved long-term disease control. > Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Dasanat 50 is used in combination with chemotherapy or as monotherapy in relapsed or refractory Ph+ ALL. It is especially valuable as a bridge to stem cell transplantation. Its central nervous system penetration helps reduce the risk of CNS relapse, a major concern in ALL treatment protocols. > Myeloid and Lymphoid Blast Crisis (CML transformation) In cases where CML progresses to myeloid or lymphoid blast crisis, Dasanat 50 offers an aggressive treatment option capable of inducing rapid cytogenetic remission. It serves as an essential pre-transplant intervention or salvage therapy for patients in advanced disease stages.

Benefits & Effectiveness

- Dual inhibition of BCR-ABL and SRC kinases - High potency against imatinib-resistant BCR-ABL mutations - CNS penetration to address or prevent leukemic CNS involvement - Rapid hematologic and cytogenetic responses in both CML and Ph+ ALL - Effective across pediatric and adult indications

Directions for Use

1. Adult Dosage – Leukemia - Chronic Phase CML: 100 mg orally once daily - Accelerated Phase CML / Blast Phase CML / Ph+ ALL: 140 mg orally once daily Duration: Continue therapy until disease progression or unacceptable toxicity. Adjust dose in case of pleural effusion, cytopenia, or QT prolongation. Regular CBC, liver function tests, and ECG monitoring are recommended. 2. Pediatric Dosage – Leukemia - Body weight 10 to <20 kg: 40 mg orally once daily - Body weight 20 to <30 kg: 60 mg orally once daily - Body weight 30 to <45 kg: 70 mg orally once daily - Body weight ≥45 kg: 100 mg orally once daily Pediatric dosing is weight-based and should be reviewed quarterly or with weight changes. Initiation of dasatinib is recommended by day 15 of induction chemotherapy for Ph+ ALL. Duration may extend up to 2 years depending on disease response and transplant eligibility.

Storage

Store at 15–30°C (59–86°F), away from moisture and direct light. Keep the tablets in the original packaging. Do not crush or split tablets. Handle with protective gloves if tablets are broken. Keep out of reach of children.

Possible Side Effects

- Common: headache, nausea, fatigue, muscle cramps, diarrhea - Hematologic: anemia, thrombocytopenia, neutropenia - Respiratory: pleural effusion, dyspnea, pulmonary edema - Cardiovascular: QT prolongation, hypertension - Others: fluid retention, skin rash, infections, liver enzyme elevation

FAQs

It is indicated for the treatment of Ph+ CML and Ph+ ALL in patients resistant or intolerant to previous therapy, and as a first-line treatment in some CML cases.
Dasatinib is more potent and effective against a wider range of BCR-ABL mutations. It also has CNS activity, unlike imatinib.
Yes, it is approved for pediatric use in Ph+ CML and Ph+ ALL based on body weight. Regular monitoring is required.
Yes, it is commonly used as a bridging therapy before allogeneic stem cell transplantation, especially in relapsed Ph+ ALL.
Monitor for pleural effusion, blood cell suppression, liver dysfunction, and ECG changes. Dose adjustment may be necessary in severe cases.

Ratings & Reviews

Reviewed by 2 Users

5/5
★★★★★
★★★★★
5★
100%
4★
0%
3★
0%
2★
0%
1★
0%

Write a Review:

✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.

✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.

💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.


Multiple orders:

✓ If you bought this product more than once on different days, you can write a separate review for each order.

💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.

Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.

Product
J**r W**n May 01, 2024
★★★★★
★★★★★

A seamless dose adjustment

My doctor increased my Dasanat dose to 50mg. Reordering from this site was easy, and the shipping was fast as always.

Product
M**l C**k Dec 26, 2023
★★★★★
★★★★★

My trusted Canadian pharmacy

For a medication this critical to my health, I need a source I can trust. This pharmacy's service to Canada has been consistently reliable and professional.

Alternatives

Combo Deals

No combo deals available at the moment.